Search results

103 results

NEWSROOM
Response to the Ukraine crisis
Dr. Falk Pharma supports APOTHEKER HELFEN e.V.
NEWSROOM
International Liver Congress™ in London
We are proud to be a sponsor and look forward to seeing you in person on our booth no. 69 or online, 22-26 June 2022!
NEWSROOM
NAFLD: Phase 2a proof of concept study of ZED1227
Dr. Falk Pharma and Zedira announce trial start for the treatment of non-alcoholic fatty liver disease. First patient enrolled in April.
NEWSROOM
Together we advance PR600
Investigational New Drug Application for PR600 expected in 3Q 2022.
NEWSROOM
Have difficulty swallowing food?
Difficulty swallowing and pain while eating may be warning signs of eosinophilic esophagitis (EoE). The first EoE Day will be held on May 22, 2022.
NEWSROOM
UEG Week 2022
Join us from October 8 – 11 in Vienna on booth no. 43 or virtually!
NEWSROOM
Collaboration and Licensing Agreement with Takeda and Zedira
To Develop First-in-Class Celiac Disease Therapy